I agree with that we shouldn't get carried away with $100+ valuations in the short or medium term. It is pretty clear that we're pretty far away from our intrinsic value based on our existing business, let alone the potential. If ACAD comes out with decent numbers and sticks to guidance, and we get another good P2 set of results it wouldn't be unrealistic to expect $30+ (since we've already hit $25 on a single result), and the premium to $50 per share is rather minimal, particularly when you convert from AUD to USD.
- Forums
- ASX - By Stock
- Ann: 2023 Annual Report to shareholders
I agree with that we shouldn't get carried away with $100+...
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.82 |
Change
0.000(0.00%) |
Mkt cap ! $2.530B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 183 | $20.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.00 | 445 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 183 | 20.810 |
1 | 28 | 20.600 |
1 | 3800 | 20.500 |
2 | 8 | 20.490 |
11 | 616 | 20.250 |
Price($) | Vol. | No. |
---|---|---|
19.310 | 1898 | 2 |
19.420 | 1262 | 2 |
19.890 | 450 | 1 |
19.990 | 589 | 3 |
20.000 | 6343 | 10 |
Last trade - 09.50am 07/05/2024 (20 minute delay) ? |
|
|||||
Last
$19.82 |
  |
Change
0.000 ( 0.38 %) |
|||
Open | High | Low | Volume | ||
$19.86 | $19.86 | $19.78 | 435 | ||
Last updated 10.08am 07/05/2024 ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online